Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 11.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 99,401 shares of the company's stock after acquiring an additional 10,460 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.18% of Molina Healthcare worth $32,742,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the company. Chicago Partners Investment Group LLC grew its holdings in shares of Molina Healthcare by 7.1% in the first quarter. Chicago Partners Investment Group LLC now owns 1,462 shares of the company's stock worth $478,000 after acquiring an additional 97 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Molina Healthcare by 4.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 416,241 shares of the company's stock valued at $137,106,000 after purchasing an additional 16,161 shares during the period. ASR Vermogensbeheer N.V. bought a new stake in Molina Healthcare during the first quarter valued at about $436,000. Earned Wealth Advisors LLC bought a new stake in Molina Healthcare during the first quarter valued at about $276,000. Finally, PNC Financial Services Group Inc. grew its holdings in Molina Healthcare by 49.1% during the first quarter. PNC Financial Services Group Inc. now owns 4,923 shares of the company's stock valued at $1,622,000 after purchasing an additional 1,622 shares during the period. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Price Performance
Shares of Molina Healthcare stock opened at $156.87 on Friday. The stock's 50-day simple moving average is $236.76 and its 200-day simple moving average is $286.88. Molina Healthcare, Inc has a 52 week low of $151.95 and a 52 week high of $365.23. The company has a market capitalization of $8.50 billion, a price-to-earnings ratio of 7.73 and a beta of 0.52. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. During the same quarter in the previous year, the firm earned $5.86 earnings per share. Molina Healthcare's revenue was up 15.7% on a year-over-year basis. As a group, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on MOH. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. JPMorgan Chase & Co. cut their price target on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a report on Tuesday, July 29th. Sanford C. Bernstein began coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target for the company. Wells Fargo & Company cut their price target on Molina Healthcare from $372.00 to $216.00 and set an "overweight" rating for the company in a report on Wednesday, July 23rd. Finally, Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and a consensus target price of $244.55.
Check Out Our Latest Analysis on MOH
Insider Transactions at Molina Healthcare
In other news, COO James Woys bought 10,000 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.